What did @bella_boo199 actually say?
Honestly? Not much, medically speaking. The transcript is a lyric fragment, "The day, the music died and they were singing by and by," which is a reference to Don McLean's "American Pie." There are no health claims here. No dosing advice, no weight loss promises, no before-and-after narrative. Just a song lyric paired with GLP-1 hashtags.
This kind of video is common in the Wegovy and Mounjaro content space. Creators build audiences through lifestyle aesthetics and music rather than explicit claims, which means traditional fact-checking has almost nothing to grab onto from the words themselves. The hashtags, though, tell a different story about what audience this content is targeting and what implicit message it may be sending.
Does the science back this up?
There is no scientific claim in this video to evaluate directly. The content is ambient, mood-based GLP-1 lifestyle content. That said, the platform context matters. Research into health misinformation on TikTok shows that implicit framing, using popular music and emotional storytelling, can shape health beliefs just as powerfully as explicit claims.
A 2022 study by Southwick et al. in the Journal of Medical Internet Research found that emotional and aesthetic framing in health TikToks significantly influenced viewer intent to seek out medications, even when no direct recommendation was made. The GLP-1 hashtag community on TikTok has been flagged by researchers for driving demand without adequately representing side effect profiles or eligibility criteria. So while there is nothing false in this transcript, there is nothing informative either, and that gap carries its own risks.
What did they get wrong (or right)?
There is nothing factually wrong here because there are no facts stated. Credit where it is due: the creator did not make any dangerous claims, did not push dosing advice, and did not claim Wegovy or Mounjaro cures anything. That is a lower bar than it should be, but plenty of GLP-1 creators do not clear it.
What is worth flagging is the hashtag combination. Mixing "wegovy" and "monjaro" (a misspelling of Mounjaro, the tirzepatide brand) in a single post implicitly groups semaglutide and tirzepatide as interchangeable. They are not. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GLP-1 and GIP receptors, a dual mechanism that produced greater average weight loss in the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine). Treating them as equivalent, even through casual hashtag use, misleads audiences about how these drugs work and what to expect.
What should you actually know?
If you landed on this video through the GLP-1 hashtag ecosystem, here is what deserves your attention. Wegovy (semaglutide 2.4mg) and Mounjaro or Zepbound (tirzepatide) are distinct medications with different mechanisms, different clinical trial results, and different side effect profiles. Neither is a lifestyle product. Both require a prescriber evaluation and ongoing medical oversight.
The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed semaglutide produced an average 14.9 percent body weight reduction over 68 weeks. SURMOUNT-1 showed tirzepatide at its highest dose produced up to 20.9 percent reduction. These are population averages, not guarantees. Side effects including nausea, vomiting, gastroparesis risk, and potential pancreatitis are real and underrepresented in aesthetic TikTok content. Compounded versions of these drugs are not equivalent to FDA-approved brand formulations and carry additional regulatory and safety considerations.
- GLP-1 medications require a diagnosis, a prescriber, and monitoring. They are not over-the-counter products.
- Hashtag culture around these drugs normalizes use in ways that can obscure who these medications are actually indicated for.
- If you are considering either medication, the conversation starts with a licensed clinician, not a TikTok feed.